R. Issels

Annals of Oncology · 2001–2018

A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from R. Issels's perspective

Ordered by how strongly the researchers R. Issels trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. (The Lancet)
  2. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. (Journal of Clinical Oncology)
  3. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. (Journal of Clinical Oncology)
  4. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. (The Lancet)
  5. A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma (Cancer)
  6. WHO classification of tumours of soft tissue and bone
  7. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. (The Lancet)
  8. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. (Journal of Clinical Oncology)
  9. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study (The Lancet Oncology)
  10. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. (The Lancet Oncology)

Their papers